0

VR23

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1624602307
CAS1624602-30-7
Molecular Weight477.88
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Examination of Novel 4-aminoquinoline Derivatives Designed and Synthesized by a Hybrid Pharmacophore Approach to Enhance Their Anticancer Activities

V Raja Solomon, Sheetal Pundir, Hoyun Lee

Sci Rep. 2019 Apr 19;9(1):6315.

PMID: 31004122

1

Genomic Characterization of Two Predominant Genotypes of Herpes Simplex Virus Type 1

K Umene, M Yoshida

Arch Virol. 1993;131(1-2):29-46.

PMID: 8101075

1

Novel, Closely Related, White Spot Syndrome Virus (WSSV) Genotypes From Madagascar, Mozambique and the Kingdom of Saudi Arabia

Kathy F J Tang, Marc Le Groumellec, Donald V Lightner

Dis Aquat Organ. 2013 Sep 24;106(1):1-6.

PMID: 24062547

1

The VR23 Antitumor Compound Also Shows Strong Anti-Inflammatory Effects in a Human Rheumatoid Arthritis Cell Model and Acute Lung Inflammation in Mice

Amanda Durkin, Hai-Yen Vu, Hoyun Lee

J Immunol. 2020 Feb 15;204(4):788-795.

PMID: 31915262

1

VR23: A Quinoline-Sulfonyl Hybrid Proteasome Inhibitor That Selectively Kills Cancer via Cyclin E-Mediated Centrosome Amplification

Sheetal Pundir, Hai-Yen Vu, V Raja Solomon, Rebecca McClure, Hoyun Lee

Cancer Res. 2015 Oct 1;75(19):4164-75.

PMID: 26238784

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode